Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR Acinetobacter

Larysa O Metelytsia1, Diana M Hodyna1, Ivan V Semenyuta1

  • 1V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Science of Ukraine, 1 Murmanska Street, 02094 Kyiv, Ukraine.

Insights

Phosphonium ionic liquids show promise as antibacterial agents against resistant Acinetobacter baumannii. These compounds also exhibit significant antioxidant properties, suggesting their potential for further development.

Area of Science:

  • Antimicrobial drug discovery
  • Materials science
  • Computational chemistry

Background:

  • Acinetobacter baumannii is a significant multidrug-resistant pathogen.
  • Ionic liquids (ILs) are being explored for antimicrobial applications.
  • Predictive modeling can accelerate the discovery of new antimicrobial agents.

Purpose of the Study:

  • To evaluate the antibacterial and antioxidant potential of phosphonium ionic liquids (PILs).
  • To validate predictive models for assessing ILs' biological activities.
  • To identify promising PIL structures for combating resistant A. baumannii.

Main Methods:

  • Utilized a previously developed model to predict antibacterial activity against A. baumannii.
  • Developed new models based on public data to evaluate antioxidant potential.
  • Synthesized six specific phosphonium salts (alkyl triphenylphosphonium and alkyl tributylphosphonium bromides with C8, C10, C12 chains).
  • Performed in vitro testing for antibacterial and antioxidant activities.

Main Results:

  • Experimental results confirmed the antibacterial activity of synthesized PILs against A. baumannii.
  • The tested PILs demonstrated significant antioxidant properties.
  • The predictive models showed good accuracy in evaluating ILs' biological activities.

Conclusions:

  • Phosphonium ionic liquids are effective against multidrug-resistant A. baumannii.
  • PILs possess valuable antioxidant capabilities.
  • These findings highlight PILs as potential lead compounds for developing new therapeutics against A. baumannii infections.